India to get Covaxin for children above 2 yrs by September: AIIMS chief Randeep Guleria

Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month, director of Delhi AIIMS Dr. Randeep Guleria told India Today TV. Delhi AIIMS has already started screening children for these trials. This started on June 7 and involves children between the age of 2 to 17. On May 12, the DCGI had granted permission to Bharat Biotech to carry out phase 2, phase 3 trials of Covaxin on children as young as two. A study by AIIMS (New Delhi) and WHO has found high sero-positivity among children. The initial findings of this study indicate that the third wave of Covid infections may not affect children more than others.